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Abstract 
 
Background  
Informed consent is required for both standard cancer treatments and experimental cancer 
treatments in a clinical trial. Effective and sensitive physician-patient communication about 
informed consent is difficult to achieve. Our aim was to train doctors in clear, collaborative and 
ethical communication about informed consent, and evaluate the impact of training on the doctor 
behavior, stress and satisfaction.  
 
Participants and Methods 
Participants were 21 oncologists from 10 Australian/New Zealand (ANZ) centers and 41 
oncologists from 10 Swiss/German/ Austrian (SGA) centers.  Oncologists were randomized to 
participate in a 1-day workshop or not. Patients were recruited before and after the training. 
Doctors were asked to submit 1-2 audiotaped consultations before and after training. Doctors 
completed outcome measures before and after completing the post-training cohort recruitment.  
 
Results 
95 consultation interactions were audiotaped. Doctors strongly endorsed the training. ANZ 
intervention doctors demonstrated a significant increase in collaborative communication 
(p=0.03). There was no effect of training on other doctor behaviors. Trained doctors did not 
demonstrate reduced stress and burnout. Patient outcomes are presented elsewhere  
 
Conclusions 
Training can improve some aspects of the process of obtaining informed consent. Methods to 
increase the impact of training are required, and may include longer training and more intensive 
follow-up.  
 
Keywords: Oncology, Consultation skills training, Physician Behavior, Decision-making, 
Clinical trials, Randomized controlled trial 
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Introduction 
The imperative for oncologists to involve patients in treatment decision-making has intensified 
over the past decade, particularly in response to changes in ethical mandates about informed 
consent (Breitsameter, 2010; Charles & Gafni, 2010; Siminoff, 2010) and evidence that shared 
decision making (SDM) results in better patient outcomes (Brown et al., 2012; Fallowfield, Hall, 
Macguire, Baum, & A'Hern, 1994 b; Gattellari, Butow, & Tattersall, 2001).  
 
 
Charles, Gafini, & Whelan (1997) have defined four components of shared decision making, 
namely the simultaneous involvement of doctor and patient in all phases of decision making, 
information exchange in both directions and by both parties, mutual deliberation on treatment 
options, and agreement on the treatment to implement. As theories of communication would 
suggest,(Albrecht, Penner, Ruckdeschel et al, 2003)  effective SDM requires both the 
transmission of information essential to decision making and relational skill to ensure that 
information is tailored to patient needs.  
 
Despite the putative benefits of SDM, many oncologists do not routinely involve patients in 
clinical decision making (Albrecht et al, 2003; Albrecht, Ruckdeschel, et al., 2003; Brown, 
Butow, Ellis, Boyle, & Tattersall, 2004; Brown, Bylund, Siminoff, & Slovin, 2010), are not 
negotiable when making final treatment decisions (Tomamichel et al., 1995), and rarely elicit or 
meet their patients’ preferences for SDM (Bilodeau & Degner, 1996; Brown & Albrecht, 2010; 
Brown, Butow, Boyle, & Tattersall, 2007; Ford, Schofield, & Hope, 2003; Gattellari et al., 2001; 
Sutherland, Llewellyn-Thomas, Lockwood, & Tritchler, 1989).   
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Some oncologists are concerned that while SDM may be largely beneficial, for some it may be 
overly burdensome, lead to confusion, and raise anxiety, particularly for patients who prefer to 
remain passive (Kaplan, Greenfield, Gandek, Rogers, & Ware, 1996). Resolving this tension, 
eliciting and meeting patients decision making needs and thereby achieving SDM is a complex 
communication process, yet many oncologists are not equipped with the skills necessary to 
achieve SDM (Brown, Butow, Ellis, et al., 2004).  The difficulty oncologists experience in 
communicating, including during decision making, has been shown to be a primary contributor 
to oncologists’ stress and burnout (Degner, Sloan, & Venkatech, 1997). Moreover, SDM is even 
more ethically pressing and harder to achieve when a clinical trial is discussed (Brown RF 
Butow P, Butt D et al, 2004; Jenkins VA, Fallowfield L, Souhami A et al, 1999). Many trial 
concepts are unfamiliar to patients, additional time is required to discuss trial participation, and 
oncologists are under pressure to increase recruitment to trials. Thus if doctors also struggle in 
having trial discussions, this might have an even stronger affect on stress and burnout.  
 
The evidence for better patient outcomes with SDM, variation in practice, the complexities and 
barriers to achieving SDM in both standard practice and clinical trial settings, and the negative 
consequences for oncologists of poor communication, all suggest that it is critical to develop, 
implement and evaluate targeted communication skills training to aid oncologists in these 
complex treatment discussions. Surprisingly, few studies have evaluated such training 
interventions, and these studies have mainly used pre-post designs (Brown et al., 2007; Jenkins, 
Fallowfield, Solis - Trapala, Landridge, & Farewell, 2005).  To fill this gap, we conducted an 
international randomized controlled trial that examined the impact of training oncologists in 
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delivering clear and ethical information about standard treatment options and clinical trials, and 
strategies to encourage SDM.  
 
We hypothesized that oncologists would find the training helpful, that their use of specific 
communication skills aligned with SDM would increase, and that oncologists’ confidence in 
their information provision would improve. We also hypothesized that these improvements 
would be reflected in reduced levels of stress and burnout. Finally, we hypothesized that 
improved oncologist communication would result in subsequent benefits for patient outcomes. 
This paper reports on doctor outcomes from the training. Patient outcomes are reported 
elsewhere (Bernhard et al., 2011). 
 
Participants  
The International Breast Cancer Study Group (IBCSG) conducted Trial 33-03 in centers in 
Australia and New Zealand (referred to as ANZ) and Switzerland, Germany and Austria 
(referred to as SGA).  
 
Medical, surgical, radiation and gynecological oncologists, working in major cancer centers or 
clinics (including private oncologists) and involved in the treatment of patients with early breast 
cancer, and their patients for whom adjuvant therapy for breast cancer was indicated, were 
eligible for this trial.  The following patient criteria were additionally required: age greater than 
or equal to 18 years, adequate knowledge in local language (English or German), and being 
mentally and physically capable of participating. Doctor participation was independent of 
previous or concurrent participation in other communication training programs. 
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Recruitment 
Local trial coordination was supported and monitored by a central coordinator for ANZ and 
SGA, respectively. Doctors in centers accruing to adjuvant breast cancer clinical trials were 
invited to join the trial in order to a) ensure the relevance of the intervention material to 
oncologists and b) increase the likelihood that we would capture consultations where clinical 
trials were discussed and thus be able to assess relevant skill uptake in our outcome measures. 
Following baseline assessment and before the scheduled training workshop, doctors were 
randomly assigned to the experimental (training workshop) or control (no training workshop) 
group, stratified by centre. Doctors in the control group were offered the training after 
completing trial follow-up.  
 
Sample description and doctor characteristics 
Target accrual was 44 doctors (22 per randomized group to detect a 0.25-point difference in the 
main patient outcome (decisional conflict) between the two groups with 90% power, α = 0.05 
and 10 patients per doctor (pre-randomisation and post-randomisation cohorts).  
 
We approached large Oncology centres with active recruitment to breast cancer trials, 10 in ANZ 
and 10 in SGA, all of which agreed to participate. At those centres, we invited all doctors 
involved in breast cancer trials to participate; 53 agreed in the SGA cohort and 21 in the ANZ 
cohort. Unfortunately we have no data on those who refused. Twelve of the interested 
physicians, all from the SGA cohort, were not eligible (11 were not randomized, 1 enrolled no 
patients), leaving a total of 62 doctors: 41 in the SGA cohort, and 21 in the ANZ cohort. Thus a 
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median number of 1.5 doctors per center (range: 1-6) enrolled in ANZ centres and a median of 4 
doctors per center (range: 2-6) enrolled in SGA centres. See Appendix 1 acknowledging the 
contribution of participating centers. At baseline, all participating doctors were asked to recruit 
to the study 5-10 consecutive new patients, both before and after the intervention, who were 
facing a treatment decision. 
 
All participating doctors randomized to the intervention completed all aspects of the training. 
Fifty-three (85.5%) doctors and 158 of their patients were assessable with regard to the primary 
endpoint for this analysis: doctor behavior (Figure 2).  In the ANZ cohort, all 21 enrolled and 
eligible doctors provided audiotaped consultations; of the 84 consultations requested (4 per 
doctor: 2 before and 2 after the intervention), 63 (75%) were audiotaped. In the SGA cohort, of 
the 41 enrolled and eligible doctors, 32 provided audiotaped consultations, for a total of 95 
(74%) audiotaped consultations. Seven of those who did not provide an audiotape were 
gynaecological oncologists from one centre, where research support was low. All 62 randomized 
and eligible doctors had complete data for the doctor-reported secondary endpoints.   
 
Insert Figure 2 here  
 
The baseline characteristics of the 62 randomized doctors and 158 audiotaped patients by 
language cohort and randomization arm are shown in Tables 1 and 2, respectively. There were 
more female doctors in the SGA than in the ANZ cohort, and for both cohorts combined, 63% of 
doctors in the control arm were female as compared to 48% in the experimental arm however 
these differences failed to reach conventional levels of statistical significance. Doctors working 
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in radiology participated only in the ANZ cohort and those from gynecology only in the SGA 
cohort. The ANZ cohort was on average 10 years older than the SGA cohort of physicians. 
Overall, there were no significant demographic or clinical differences between patients with 
audiotaped consultations who were seeing experimental versus control doctors or between those 
who were recruited to the pre- and post-randomization cohorts in the ANZ and SGA cohorts, 
respectively.  
Characteristics of doctors with (n = 53) and without (n =9) audiotapes were compared and no 
differences were detected for randomization arm (χ2 (1) = 1.17, p > .28), gender (χ2 (1) = 1.68, p 
> .20), institutional affiliation (χ2 (1) = 1.56, p > .45),  nor previous training in communication 
(χ2 (1) = 0.809, p > .35); in all cases Fischer exact test agrees with chi-square result for lack of 
significance. For doctor specialty (χ2 (3) = 5.61, p > .10; Fischer exact p < .007) results suggest a 
difference in doctor specialty with regards the  presence or absence of audiotapes. Inspection of 
the frequencies reveals that seven (7) of the nine (9) doctors without tapes were gynecologists. 
Physicians without tapes were also younger (mean = 32.3, s.d.=3.53) than those with tapes (mean 
= 39.70, s.d. = 8.82) (t (1) = 3.02, p < .02).  
Insert Table 1 here 
Insert Table 2 here 
 
Procedure 
Participating patients completed questionnaires before, 2 weeks after, and 4 months after their 
initial consultation. All participating doctors were asked to audiotape two of these initial 
consultations and submit them to the research team. At completion of this pre-training patient 
recruitment, doctors were asked to complete a short questionnaire eliciting demographic and 
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practice details, stress and burn-out, and confidence in their provision of information to patients. 
Following this, the doctors were randomized (see Figure 1), and experimental arm doctors 
completed the intervention. All doctors then recruited a further 8-10 patients to the study, again 
audiotaping two of these patients’ initial consultations and providing them to the study team. On 
completing the post-randomization cohort recruitment (about 5 months after randomization), 
doctors were given the follow-up questionnaire assessing stress and burnout, and confidence in 
their information provision. In the experimental group only, doctors also rated their satisfaction 
with the training immediately after and 5-months following the training workshop. Institutional 
Review Board approval to conduct this study was obtained from all participating centers.  
 
Insert Figure 1 here  
 
Training intervention 
The training consisted of a seven-hour interactive face-to-face workshop with a follow-up 
telephone call one month later. The elements of the training workshop were evidence-based, and 
used accepted adult learning principles (Brown, Butow, Butt, Moore, & Tattersall, 2004).  
Strategies taught were based on our earlier work in which a model of communicating about 
clinical trials and fostering SDM in oncology consultations was developed after intense multi-
disciplinary review of audiotaped consent interviews, and consensus meetings (Brown, Butow, 
Butt, et al., 2004). Training based on this model was shown to be acceptable and effective in a 
phase II trial (Brown et al., 2007). The training incorporated written and oral materials that 
presented principles and strategies (2 hours), a video modeling ideal behavior (30 mins), role-
play practice with an actor-patient and expert facilitator (4 hours), and individualized feedback 
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on audio-taped consultations with actual patients (30 mins). The training workshop focused on 
four key concepts: a) establishing a SDM framework, b) structuring information into a 
recommended sequence or order, c) ensuring the discussion of key information in a clear manner 
and d) avoiding coercive communication (Brown, Butow, Butt, et al., 2004). Example 
behaviours for each of these concepts are shown in Table 3.   
 
The training workshops were held at the participating centers and conducted in the local 
language (English or German) by clinical psychologists with experience in interactional skills 
training (authors PB, JB and RB). Before the training workshop, participants in the experimental 
group were expected to have read the strategies document and a set of articles about shared 
decision-making (Charles CI, Gafni A, Whelan T, 1997; Gattellari M, Butow PN, Tattersall 
MHN, 2001; Brown RF et al, 2004; Brown RF, Butow PN, Ellis P et al, 2004).  Baseline 
audiotapes were transcribed and analyzed by the research team using the Decision Analysis 
System for Oncology (DAS-O) (Brown, Butow, et al., 2010) developed by our team to capture 
essential elements of shared decision-making according to our model. For doctors in the 
experimental group only, confidential written feedback concerning the strengths and 
opportunities for improvement in SDM demonstrated on the tapes was provided during the 
training workshop. One month later, training workshop participants received an individual 
telephone call from the trainer to discuss challenges experienced when implementing strategies, 
and to reinforce and extend learning.  
 
Coding of doctor behaviors in audio-taped consultations 
 11 
The primary doctor outcome for the study was change in SDM behaviors demonstrated in audio-
taped consultations with real patients, coded using the DAS-O coding system (Brown et al, 
2010).  The coder identifies the presence (1) or absence (0) of key components of SDM in three 
subscales:  
i) establishing a SDM framework (22 items), e.g. introducing joint decision making, inviting 
comments and questions, offering choice;  
ii) providing clear and unbiased information about treatment options (28 items); this subscale is 
comprised of items on ordering information clearly and providing essential information (e.g. 
establishing a shared understanding of the patient’s situation before describing treatment 
options, describing the benefits and side effects of treatment options), using techniques to aid 
patient understanding (e.g. avoiding jargon, drawing diagrams), disclosing important facts 
(e.g. availability of the trial treatment off trial) and avoiding coercion (e.g. avoiding language 
implying exclusion or inclusion as a result of treatment choice); 
iii) providing essential information about clinical trials (used only when clinical trials are 
discussed) (14 items), e.g. explaining equipoise, randomization and the benefits and 
disadvantages of trial participation.  
Total scores are calculated for each subscale by summing individual item scores, with higher 
total scores indicating that more behaviors were displayed.  Two raters applied the DAS-O 
coding system to the consultations. To test inter- and intra-rater reliability, they re-coded 10% of 
each other’s and 10% of their own consultations. Inter- and intra-rater reliability as measured by 
kappas were on average 0.54 for presence of behaviors across the three subscales. Due to the 
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small number of clinical trials discussed (in 34 of 158 consultations), results for the last subscale 
are not reported. 
 
Oncologist Reported Outcomes 
Satisfaction with the training workshop - Oncologists completed 15 study-specific items 
measuring satisfaction with the training workshop.  Five-point Likert scales were used with 
anchors at ‘strongly agree’ and ‘strongly disagree’. Raw scores were summed to produce scores  
ranging from 15 to 75, with higher scores indicating greater satisfaction with training.  
 
Confidence in information provision - Oncologists completed a six item scale measuring their 
confidence in the amount, clarity and completeness of information they provided, their ability to 
involve the patient in decision making, and patients’ understanding. Five-point Likert scales 
were used with anchors at ‘strongly agree’ and ‘strongly disagree’. Raw scores were summed to 
produce a total score (6-30) with higher scores representing higher levels of satisfaction with 
these aspects of consultations. This scale was developed by our group and used in a previous 
study of communication about clinical trials (Ellis, Butow, Simes, Tattersall, & Dunn, 1999).     
 
Doctor stress and burnout was measured using the Maslach Burnout Inventory [MBI] as used by 
Rameriz et al.(Ramirez, Graham, Richards, Gregory, & Cull, 1996) Separate scales measure 
emotional exhaustion [EE, feelings of being emotionally overextended and exhausted by one’s 
work], depersonalization [DP, an unfeeling and impersonal response toward recipients of one’s 
care], and personal accomplishment [PA, feelings of competence and successful achievement in 
one’s work]. Global measures of job stress and satisfaction are derived by summing the item 
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scores within each category with high scores on the emotional exhaustion and depersonalization 
scales and low scores on the personal accomplishment scale indicating more stress. 
 
Statistical Methods 
Language cohorts were defined by location: ANZ (English) and SGA (German).  Because of 
potential cultural differences between the SGA and ANZ centers, all results are presented 
separately by language.  
 
The primary doctor outcome measure was change in doctor behavior as determined by the 
audiotaped consultations and the subscale total scores of the DAS-O coding system. As only 
23% of the audio-recorded treatment consultations contained a clinical trial discussion, we were 
unable to code for systematic changes in trial discussions due to the comparative rarity of such 
discussions. Doctors’ self-reported stress and burnout as well as satisfaction with information 
provision and the training, were secondary outcomes. Demographic and practice characteristics 
of doctors in the experimental and control groups were tabulated by language cohort. 
Respectively for each language cohort, two-sided Fisher’s exact test was used to compare 
categorical variables between randomization groups, and two-sided Wilcoxon Rank Sum test 
was used to compare continuous variables between randomization groups.   
 
Analyses were conducted to examine potential differences in the change from pre- to post-
randomization between the experimental and the control groups for each outcome measure.  This 
consisted of creating random effects linear regression model (i.e., mixed effects model) for 
physicians with multiple patients (Laird & Ware, 1982) at the pre- and post-randomization data 
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collection points.  These models include a random effect for physicians to account for the fact 
that physicians can have multiple patients (nested) in the sample (Laird & Ware, 1982). A 
separate regression model was created for each of the subscales on the DAS-O as well and the 
three indicators of stress and burnout within each language cohort. Covariates included in each 
model were physician age, gender and specialty. To enhance the interpretability of the change in 
scores over time and or differences between the randomization arms, the mean of the difference 
between the experimental and control groups of the pre- to post-randomization changes was 
defined as: (Experimentalpost -Experimentalpre) – (Controlpost - Controlpre).  Effect size (ES) was 
calculated as the absolute value of the estimated mean difference divided by the product of the 
standard error and the square root of the degrees of freedom. The analyses used SAS 9.2 (SAS 
Institute Inc., Cary, NC, USA).   
 
The study was powered to detect a clinically significant change in the primary patient outcome, 
patient decisional conflict two-weeks post-consultation.  All secondary endpoints, including 
doctor outcomes, are exploratory in nature, and tests are not adjusted for multiple comparisons. 
 
Results 
Acceptability of training by doctors 
Overall, satisfaction with the training was high. All doctors in the experimental group completed 
this scale. The post-randomization, median scores for satisfaction with training were 57.5 (range 
= 41-75) and 56.0 (range = 38 - 73) for SGA and ANZ, respectively. Qualitative feedback was 
positive. All but one participant would recommend the training to others, and all but one valued 
highly the strategies suggested in training as well as the opportunity to practice these in role-
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plays. One doctor noted that “the training was very good, and I will pass this material on to my 
junior doctors.” 
 
Doctor Behavior 
Table 3 shows the results of mixed effects modeling exploring differences in the change of 
doctor behavior scores as assessed by subscales of the DAS-O between randomization groups. In 
the ANZ cohort, the estimated population mean of the difference for establishing the SDM 
framework (subscale 1 of the DAS-O) was statistically significant, indicating that after the 
training workshop, doctors in the experimental group within the ANZ cohort displayed more 
behaviors designed to establish the SDM framework than those doctors in the control group 
(estimated population mean difference=3.42, s.e. = 1.50, ES=0.30, p=0.03).   However, the effect 
size was small. There was no effect for this variable for SGA doctors (estimated population mean 
difference=0.52, s.e. = 1.39, ES=0.04, p=0.71).  Figure 3, which displays the mean scores for 
establishing the SDM framework by randomization group and language cohort for the pre-
randomization and post-randomization patient-doctor consultations, shows that the driving force 
in the significance of this endpoint is from a decline in SDM in the ANZ control group in 
conjunction with an increase in SDM in the ANZ experimental group.  There were no significant 
differences pre- and post-randomization in other subscales of the DAS-O, although the direction 
of effects was generally in the hypothesized direction.  
Insert Table 3 here 
Insert Figure 3 here 
 
Confidence in information provision 
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There were no significant changes from pre- to post-randomization between the experimental 
and control groups in their confidence in their own information provision. 
 
Stress and Burnout  
Prior to randomization there were no significant differences in stress and burnout scores between 
the experimental and control groups in either the SGA or ANZ cohorts.  Figure 4 displays the 
mean scores for personal accomplishment by randomization group and language cohort, pre-
randomization and 5-months post-randomization.  In the SGA cohort, doctors in the 
experimental group maintained their levels of personal accomplishment post-training, while in 
the control group, doctors’ sense of personal accomplishment appeared to decline.  Significance 
was driven by this decline in the control group.  The estimated population mean of the difference 
between the experimental and the control groups for personal accomplishment indicates that 
those doctors in the training group had higher levels of personal accomplishment than those in 
the control group from pre- to post-randomization (estimate=7.17, s.e. = 3.25, ES=0.31, p=0.03 - 
see Figure 4). There were no significant differences of pre- and post-randomization scores 
between the experimental and control groups on other stress and burnout subscales. 
Figure 4 about here.  
 
Discussion 
The primary aim of this research was to demonstrate the efficacy of an oncologist-focused 
communication skills training intervention to increase oncologist use of SDM skills during 
treatment decision making consultations (including clinical trials) with early breast cancer 
patients. Overall, the doctors reported that the training workshop was very helpful and that they 
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would recommend it to others. There was a significant group difference in one element (but not 
others) of doctors’ behavior as captured by the DAS-O coding scheme: establishing an SDM 
framework. Doctors in both cohorts maintained or slightly increased behaviors designed to 
establish a SDM framework after training, while the control group declined in this behavior. It is 
possible that all doctors (including controls) were attempting to appear as skilled as possible in 
the pre-training assessment, but that control doctors relapsed into more usual behavior in the 
post-training assessment. The demand characteristics of this novel situation, in which they were 
being filmed and audited, may have increased their motivation to behave in socially desirable 
ways (Pringle M, Stewart-Evans C, 1990; Penner LA, Orom H, Albrecth T et al, 2007). Most 
oncologists know about, and are generally favorable towards, SDM (Charles and Shepherd et al 
papers); thus they may have had sufficient background knowledge to guide their behavior when 
motivated. However, with greater familiarity, these demand characteristics may have lessened 
for control doctors. This raises an interesting methodological point for communication trials in 
the future. Perhaps measuring behavior at two time points is not sufficient, and rather an 
averaged baseline over several assessment points is required to overcome social desirability 
effects. 
 
In comparison, the experimental group was perhaps motivated to continue focusing on SDM 
behaviors and actually increased their skills due to training. This is in line with previous studies 
(for example, Edwards & Elwyn, 2004) that have demonstrated that communication skills 
training can improve doctors’ attitudes towards and skills in SDM. Our intervention strongly 
endorsed SDM and provided a clear evidence base that SDM approaches improve patient and 
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doctor outcomes. Furthermore, the experimental doctors received specific strategies and skills 
training in SDM approaches, which likely increased their use of these behaviours.  
 
Other doctor behaviours targeted by the intervention however, (information flow, clarity of 
information provision and lack of coercion) were not impacted. We presented to participants an 
optimal information flow; however this incorporated clinical trial discussions and since these 
were few in our sample, the impact may have been therefore reduced. The strategies taught to 
increase information clarity and avoid coercion were, on the other hand, general to all treatment 
discussions, so it is not clear why these did not improve post-training. We did notice in role-
plays during the intervention workshops, that doctors struggled more with the subtle SDM skills, 
rather than more overt coercive and information giving elements; in focusing on SDM we may 
have under-emphasised coercion and information-giving in role-play practice. Perhaps these 
latter elements would be better practiced within more challenging scenarios.  
 
The secondary aims were to determine the overall effect of training on oncologists’ confidence in 
their information provision and on their levels of stress and burnout, within an experimental 
design.  The training workshop did not improve confidence in providing clear and unbiased 
information. This may have been due to a ceiling effect, with most participating doctors scoring 
well on these subscales prior to randomization. Doctor stress and burnout were also not affected 
by the training workshop, although in SGA the training workshop appeared to help doctors 
maintain a feeling of personal accomplishment over time. In the literature, the causes of stress 
and burnout have been shown to be multi-factorial, with system, patient and doctor factors 
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contributing to burnout (Ramirez A et al, 1996).  It is perhaps not surprising that targeting one 
factor (communication efficacy in the doctor) was not sufficient to cause an appreciable change.  
 
Several limitations to this study need to be acknowledged. First, as only 23% of the audio-
recorded treatment consultations contained a clinical trial discussion we were unable to code for 
systematic changes in clinical trial discussions due to the comparative rarity of such discussions. 
We also therefore did not obtain data on final accrual to clinical trials.  Second, while we 
emphasized that consecutive patient recruitment was essential, we have no way of knowing that 
this was achieved; it is possible that doctors selected certain patients and avoided others, thus 
biasing their results. However, it is likely that doctors in both arms of the study would have done 
this; therefore we believe that group differences are unlikely to be affected. Third, while we 
sought an equal number of patients per doctor, there was variation in the numbers per doctor 
which could have impacted our results; however, the mixed modeling with doctor as a random 
effect addressed this issue as much as possible by accounting for the variance attributed to 
multiple patients per doctor. Fourth, the preponderance of oncologists with no audio tapes 
available were gynecologists, so the degree to which these conclusions are applicable in that 
specialty specifically is limited. Finally, the study was powered for patient outcomes, and it is 
possible that there was not sufficient power to detect important but subtle differences in doctor 
behavior that work together cumulatively to enhance the patient’s experience.  
Nonetheless, the fact that increases in or maintenance of SDM behaviors were achieved after 
only seven hours of training suggests that improvement in skills can be achieved at low cost with 
minimal time commitment for trainees. However, the improvements were neither as large nor as 
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consistent across measures as we had hoped for. It appears that seven hours may not be sufficient 
to generate large changes in behavior and doctor outcomes. The impact of the training workshop 
may have been greater had it been longer than 1 day, with two follow-up phone calls. Providing 
more opportunities for facilitated practice over a 2-3 day period may have consolidated learning. 
Communication skills training workshops which have been proven efficacious have been at least 
three days in length (Fallowfield et al, 2002; Razavi, Delvaux, & Marchal, 2002).     
 
Unfortunately, direct comparisons of communication skills training workshops of different 
lengths have not been reported in the literature, and a recent review of the available evidence 
from high quality trials concluded that generalization beyond the specific training workshop 
evaluated is not possible at this stage.(Barth & Lannen, 2011) Finding a balance between 
practicality and efficacy is always a challenge, and many clinicians struggle to find time to attend 
longer workshops. Nevertheless, achievement of enduring and more extensive change may 
require a longer commitment. Shorter, but more frequent sessions (for example short workshops 
once a month, or weekly 1-hour webinars) may be an effective but still feasible way of 
delivering such training.  
 
Alternatively, the training workshop may generate greater change if regarded as more salient.  In 
Australia, the authors have been delivering training workshops in gaining informed consent to a 
specific clinical trial, at the trial activation meeting. Investigators report (informally) finding the 
training very salient, as they will be using the skills gained in a specific setting in the near future. 
These training workshops have proven very popular, accessible and effective, with trial 
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coordinators reporting increased clinician involvement and patient recruitment, and may be more 
effective than generic SDM workshops.  
 
In summary, we were able to demonstrate that a 1 day consultation skills training workshop in 
gaining consent to standard treatment and clinical trials maintained shared decision making 
behaviors. Future research should explore the trade-off between length and efficacy of 
communication skills training.  
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Table 1 
Pre-randomization characteristics of 62 randomized doctors by randomization arm 
 
 
 SGA ANZ  
 Control  Experimental  Control  Experimental  Χ2(P value) 
 (No Training) (Training) (No Training) (Training)  
 N N N   N  
n 20 21 11 10  
Gender      
Male 7 8 6 5 .043 (.835) 
Female 13 13 5 5  
Specialty       
Medical 
Oncology 
6 5 6 6 .709 (.701) 
Radiology  - - 3 3  
Surgeon 2 2 2 1  
Gynaecologist 12 14 - -  
Institution      .976 (.323) 
Public  20 20 7 7  
Private - 1 - -  
Both - - 4 3  
Previous 
training in 
communication 
skills 
6 4 5 6 .200 (.655) 
 med (range) med (range) med range med range F (p) 
Age in years 33 (27,  44) 34 (24, 48) 47 (33, 58) 44 (38, 62) 46.83 (<.0001)a 
Previous years 
of practice 
6 (1, 18 ) 6 (1, 24) 16 (2, 35) 21 (8, 37) 1.50 (0.226) 
Mean number of 
patients per 
doctor 
15 (5, 200) 15 (3, 55) 15 (5, 50) 8 (3, 20)  
 
1.21 (0.513) 
 2 
recruited to 
trials over 6 
months* 
*refers to any trial; Fischer’s exact is reported for chi-square comparisons; lsmeans is reported for means test both due to small cell 
sizes. Note: a is comparing ANZ to SGA. 
Table 2:  
Patient characteristics by doctor’s randomization arm and language cohort for those 158 patients who had audio-taped 
consultations  
 
 SGA ANZ  
 Control  Experimental  Control  Experimental  
 (No Training) (Training) (No Training) (Training)  
 N % N % N % N %  Chi sq (p)  
n 46 100 49 100 34 100 29 100  
Nodal Status          
Missing - - - - 1 3 - - 1.54 (.214) 
Negative 32 70 27 55 20 59 15 52  
Positive 14 30 22 45 13 38 14 48  
Grade of tumour          
1 5 11 7 14 9 26 5 17 .068 (.967) 
2 24 52 24 49 14 41 10 34  
3 17 37 18 37 11 32 12 41  
Missing - - - - - - 2 7  
Hormone receptor status          
Negative 8 17 10 20 5 15 9 31 3.425 (.180) 
Positive 36 78 39 80 26 76 15 52  
Unclear 2 4 - - 3 9 5 17  
Training in a medical field 7 15 5 10 9 26 4 14  
 med (range) med (range) med (range) med (range) F (p) 
Age in years 58 (24, 84) 58 (35, 86) 51 (28, 81) 52 (34, 79) 3.45 (.07) 
Tumor size (cm) 1.8 (0.4, 5) 2.3 (0.8, 12) 1.6 (0.5, 22) 2 (0.3, 9 2.40 (0.123) 
 
Note: Fischer’s exact is reported for chi-square comparisons; lsmeans is reported for means test both due to small cell sizes. 
 Table 3. Sample behaviours under each key concept 
 
Establishing the 
SDM framework 
Structuring 
information 
Fostering 
understanding  
Avoiding coercion 
Introduce joint 
decision-making 
Follow a consultation 
pathway 
Categorise 
information 
Spend time on all 
treatment options 
Check patient 
understanding  
Establish joint 
understanding of 
patient situation, 
before introducing 
treatment options 
Avoid jargon Avoid minimizing the 
impact of any 
treatment 
Explicitly offer choice 
between options 
Discuss standard 
treatment before 
introducing a trial 
Use diagrams, 
pictures and analogies 
Avoid differential 
framing of outcomes 
Portray the patient as 
active 
Give space for 
patients to voice 
preferences 
Summarise 
information 
Encourage individual 
choice 
 
Table 4  
Summary of differences between experimental and control groups of doctor outcome measures* estimated using mixed models 
linear regression by language cohort  
 
 Language 
Cohort 
*Estimate
d Mean 
Difference 
Standard 
Error 
Lower 95% 
Confidence 
Limit 
Upper 95% 
Confidence 
Limit 
p-
value** 
Establishing the shared 
decision making framework 
 
SGA 
 
0.52 
 
1.39 
 
-2.25 
 
3.29 
 
0.71 
 ANZ 3.42 1.50 0.42 6.41 0.026 
Providing clear and unbiased 
information 
      
Ordering information 
clearly 
SGA -1.13 0.69 -2.51 0.24 0.11 
 ANZ 0.60 0.62 -0.63 1.83 0.33 
Aiding patient 
understanding 
SGA 0.63 0.59 -0.54 1.80 0.29 
 ANZ 1.00 0.67 -0.35 2.35 0.14 
Disclosure SGA -0.21 0.37 -0.99 0.57 0.57 
 ANZ -0.20 0.26 -0.80 0.40 0.47 
Avoiding coercion SGA 0.10 0.49 -0.87 1.07 0.84 
 ANZ 0.53 0.45 -0.36 1.43 0.24 
       
Satisfaction with information 
provision 
 
SGA 
 
2.06 
 
1.60 
 
-1.13 
 
5.26 
 
0.20 
 ANZ 1.70 2.14 -2.60 5.99 0.43 
Doctor stress and burnout       
Depersonalization SGA 2.30 5.62 -8.96 13.56 0.68 
 ANZ -3.67 7.00 -17.74 10.40 0.60 
Emotional Exhaustion SGA 3.13 3.51 -3.92 10.18 0.38 
 ANZ 4.18 4.32 -4.50 12.85 0.34 
 2 
Personal Accomplishment SGA 7.17 3.25 0.65 13.70 0.0318 
 ANZ -6.67 4.02 -14.76 1.41 0.10 
*(Exppost -Exppre) – (Controlpost - Controlpre) 
**p-value is the between-group comparison of pre vs. post differences. 
Note: Doctors in the experimental group only completed “Satisfaction with training” questionnaire, thus; a between-group comparison 
cannot be made.  
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Figure 1.  Trial design of IBCSG 33-03 
 
Registration of doctors 
 
 
Pre-cohort: Consultations of 2 patients per doctor (of 5-10 patients recruited per 
doctor) audio-taped. 
 
Doctor measures assessed after recruitment of pre-cohort and just prior to 
randomization 
Experimental Group 
            Training workshop  
 
Doctors rated satisfaction with 
workshop immediately after it  
Control Group 
No training 
 
Post-cohort: Consultations of 2 patients per doctor (of ≥8 patients recruited per 
doctor) audio-taped.  
 
Doctor measures assessed 5 months after training  
Randomization of doctors 
 3 
Figure 2. Consort Diagram 
 
 
 
 4 
 
Figure 3.    
Mean scores of establishing the shared decision making framework, by randomization 
group and language cohort, plotted against data collection point for 62 randomized doctors 
 
 
* Note that Figures 3 and do not take into consideration the effect of multiple patients per doctor. 
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Figure 4.   
Mean scores of doctor stress and burnout through personal accomplishment by 
randomization group and language cohort plotted against data collection point for 62 
randomized doctors 
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APPENDIX OF PARTICIPATING CENTERS, DOCTORS AND LOCAL 
COORDINATORS 
Australia 
St Vincents Hospital, Melbourne: R. Snyder, W. Burns, A. Dowling, Nadia Ranieri 
Maroondah Hospital, Maroondah: J. Chirgwin, Suzanne Giddings 
Royal Prince Alfred Hospital, Sydney: S. Pendlebury, J. Beith, A. Hamilton, Gina Bark 
Sir Charles Gairdner Hospital, Perth: C. Saunders, L. Jackson, N. Spry, F. Cameron, M. Taylor, 
R. Chee, Anna Davies, Philippa Kelly 
Flinders Medical Center, Adelaide: B. Koczwara, Alison Richards 
Westmead Hospital Sydney: V. Ahern, P. Harnett, Mary Cooper 
Nepean Cancer Care Center, Penrith: N. Wilcken, Penny Murie 
New Zealand 
Auckland Hospital, Auckland: P. Thompson, V. Harvey, Joline Ong 
Waikato Hospital, Hamilton: I. Campbell, Jenni Scarlet 
Dunedin Hospital, Dunedin: D. Perez, Alison Wylie 
Switzerland 
Kantonsspital St. Gallen: B. Thürlimann, A. Casty, M. Hoefliger, A. Müller 
Inselspital Bern: S. Aebi, M. Rabaglio, C. Baumann 
Germany 
Universitätsklinik Frankfurt: M. Liszka, S. Loibl, K. Schmidt, V. Gies, H. Trümper 
Frauenklinik Technische Universität München: K. Miska, U. Euler, D. Paepke, K. Gauger, A. 
Baumgärtner 
Universitätsfrauenklinik Kiel: C. Crohns, I. Meinhold-Heerlein, A. Ulrich, S. Grebe, J. Haller, A. 
Lüesse, J. Dürkop 
Krankenhaus München Schwabing: Andrea Schulte, Alexandra von Holle, Sabine Schmid 
Universitätsklinikum Jena: O. Camara, J. Hermann, A. Egbe, A. Kavallaris, H. Winzer, B. 
Härtwig, S. Krauspe 
Austria 
Wilhelminenspital Wien: H. Lass, T. Scholl, M. Brunbauer M. Riegler-Keil 
Allgemeines Krankenhaus Wien: C. Singer, Y. Yücel, D. Gschwantler-Kaulich, A. Fink-Retter, 
D. Bikas, M. Tea  Landeskrankenhaus Feldkirch: M. Knauer, R. Köberle-Wührer, P. Elke 
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